Olaf van den Broek

Olaf van den Broek is currently the Country Medical Head Oncology and Hematology at Stemline Therapeutics. Prior to this role, Olaf held various positions at companies such as NVFG, Celgene, BD, and GSK, focusing on medical affairs, advisory roles, and account management. Olaf's educational background includes a Ph.D. in Medicine from Utrecht University and a Master of Science in Molecular genetics from Wageningen University & Research.